Today's Top Loser Stocks - FRAN, ELX, LFVN, CHTP, SVU

Los Angelas, CA -- (SBWIRE) -- 12/06/2012 -- Francesca's Holdings (NASDAQ:FRAN), which faded badly on positive quarterly results Wednesday, tumbled 7% in heavy trading. On Wednesday, the stock rose as much as 11% intraday, after the retailer beat views with quarterly earnings and sales that climbed 71% and 44%, respectively. But Francesca's closed less than 1% higher and below its converging 50-day and 200-day moving averages.

Can FRAN Bounce Back? Find Out Here

Emulex Corporation (NYSE:ELX), the leading provider of converged networking solutions, and Endace Limited (EDA.L), a leading supplier of network visibility infrastructure products, announced today that Emulex has issued a Takeover Notice, under the terms of the New Zealand Takeovers Code, pursuant to which Emulex will make an offer to acquire all of the outstanding equity interests in Endace in an all cash transaction.

Can ELX Recover After The Recent fall? Find Out Here

Lifevantage Corporation (NASDAQ:LFVN) are down 22.44% to $1.94 on trading volume of 1.6 million shares. The company announced a voluntary recall of its Protandim dietary supplement due to health concerns. The 52-week low is $1.28. Lifevantage Corporation (Lifevantage) is engaged in the identification, research, development, manufacture and distribution of advanced nutraceutical dietary supplements, including its product, Protandim, the Nrf2 Synergizer and its anti-aging skin care product, LifeVantage TrueScience.

How Should Investors Trade LFVN After Today’s Rally? Find Out Here

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) released preliminary results for its Phase III clinical study, called 306b, which evaluated the efficacy and safety of Northera, the company's drug candidate for symptomatic neurogenic orthostatic hypotension (NOH) associated with Parkinson's disease. NOH is associated with a sharp drop in blood pressure -- patients often have trouble standing for long periods of time and will generally fall more often. Falling is a big problem with Parkinson's disease patients and can lead to severe complications and even death. Therefore, Northera could be an important treatment in this disease.

Should Investors Buy CHTP After The Recent Drop? Find Out Here

Supervalu (NYSE:SVU) is nearing a deal to divest its retail chains like Albertsons and Save-A-Lot to Cerberus Capital Management, subsequent to discussions on a full takeover stalling out, said knowledgeable sources. Selling off the chains would afford Supervalu cash with which to pay down a portion of its more than $6 billion in debt, along with permitting it to concentrate on divesting or restructuring its nine other chains. For three consecutive years, sales at Supervalu have fallen, and are projected to slide a further 4.4 percent to $34.5 billion in its fiscal 2013.

Can SVU Jump Again? Find Out Here

DISCLAIMER
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com